about
Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementationAnti-platelet drug resistance in the prediction of thromboembolic complications after neurointerventionEfficacy and Safety of Novel Oral P2Y12 Receptor Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Systematic Review and Meta-Analysis.Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.Antiplatelet therapy in acute coronary syndromes.Thienopyridines in Acute Coronary Syndrome.Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?ST elevation myocardial infarction: recent advances and updates.Antiplatelet Resistance-Does it Exist and How to Measure it?Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.
P2860
Q27011524-E40A8BCB-53A9-42A7-B240-5D4B140130E7Q34316378-30CC1508-ABA6-46F7-B688-7924406D5468Q36237726-9ED52059-3D6E-49E6-A7E1-EF04F85DA298Q37618798-6180A6DE-DFAA-4A4F-9D86-60E477B9953DQ37798110-C501A03C-0428-4B88-8952-0C93D106D3A3Q37838124-473529FD-75C6-4242-A419-B2AE990BCF16Q37878982-9BB1074D-6505-40A9-B195-C5733EEC379FQ38263602-DD3CBDA3-85CD-419E-8DD0-77FE48ECC40BQ40014803-CD1EFE48-F62D-431C-AFCB-8B6886A1ECCAQ42164176-337BD557-BA43-4D7B-A360-48BC5206BB04Q46355429-49350BEB-C08C-4289-8B8B-A434F9C432AB
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clopidogrel response variability, resistance, or both?
@ast
Clopidogrel response variability, resistance, or both?
@en
Clopidogrel response variability, resistance, or both?
@nl
type
label
Clopidogrel response variability, resistance, or both?
@ast
Clopidogrel response variability, resistance, or both?
@en
Clopidogrel response variability, resistance, or both?
@nl
prefLabel
Clopidogrel response variability, resistance, or both?
@ast
Clopidogrel response variability, resistance, or both?
@en
Clopidogrel response variability, resistance, or both?
@nl
P1476
Clopidogrel response variability, resistance, or both?
@en
P2093
Stephen D Wiviott
P304
P356
10.1016/J.AMJCARD.2006.09.010
P407
P577
2006-11-20T00:00:00Z